13
Participants
Start Date
September 14, 2021
Primary Completion Date
November 30, 2022
Study Completion Date
November 30, 2022
InPen®
A smartpen that has been FDA approved for children with diabetes age seven years and older that uses an app on a smartphone to help calculate insulin doses using the amount of carbohydrates that will be consumed at a meal along with what the current blood sugar reading is, to give a correction dose as well. The InPen app also serves as a log book to record insulin doses given, blood sugar at the time of a meal, and amount of carbohydrate eaten.
Mayo Clinic in Rochester, Rochester
Lead Sponsor
Mayo Clinic
OTHER